Medroxyprogesterone acetate as an injectable contraceptive--its utility in Indian women
Jawalekar, K.S.; Chitale, M.V.
Journal of Obstetrics and Gynaecology of India 23(1): 55-57
1973
ISSN/ISBN: 0971-9202 PMID: 4806729 Document Number: 494921
Document emailed within 1 workday
Related Documents
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Cuong, D.T.; My Huong, N.T. 1996: Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and cyclofem, in Vietnamese women Contraception 54(3): 169-179
Lali, P.; Chandra, L.; Gupta, R.P. 1996: Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: A preliminary study Contraception 53(6): 363-365
Govender, Y.; Avenant, C.; Verhoog, N.J.D.; Ray, R.M.; Grantham, N.J.; Africander, D.; Hapgood, J.P. 2014: The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor Plos one 9(5): E96497
Hu, E.; Ikeako, L.C.; Obiora-Okafor, N.C. 2012: The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 21(3): 266-271
Hu, E.; Ikeako, L.C.; Obiora-Okafor, N.C. 2012: The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 21(3): 266-271
Cursino, K.; Sider, M.; Pavin, E.J.ão.; dos Santos, P.d.N.é S.; Bahamondes, L.; Zantut-Wittmann, D.E.; Fernandes, A. 2016: Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 21(1): 22-29
Tomasicchio, M.; Davids, M.; Pooran, A.; Theron, G.; Smith, L.; Semple, L.; Meldau, R.; Hapgood, J.Patricia.; Dheda, K. 2019: The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor Journal of Infectious Diseases 219(8): 1329-1337
Modesto, W.; Bahamondes, M.V.; Bahamondes, L. 2015: Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate Journal of Women's Health 24(8): 636-640
Thurman, A.; Kimble, T.; Hall, P.; Schwartz, J.L.; Archer, D.F. 2013: Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics Contraception 87(6): 738-743
Harel, Z.; Wolter, K.; Gold, M.A.; Cromer, B.; Bruner, A.; Stager, M.; Bachrach, L.; Hertweck, P.; Nelson, A.; Nelson, D.; Coupey, S.; Johnson, C.C.; Burkman, R.; Bone, H. 2010: Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study Journal of Pediatric and Adolescent Gynecology 23(4): 209-214
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Lizarelli, P.íc.M.; Martins, W.P.; Vieira, C.S.; Soares, G.M.; Franceschini, S.íl.A.ôn.; Ferriani, R.A.; Patta, M.C. 2009: Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women Contraception 79(1): 35-40
Parveen, L.; Chowdhury, A.Q.; Chowdhury, Z. 1977: Injectable contraception (medroxyprogesterone acetate) in rural Bangladesh Lancet 2(8045): 946-948
Harris, T.G.; Miller, L.; Kulasingam, S.L.; Feng, Q.; Kiviat, N.B.; Schwartz, S.M.; Koutsky, L.A. 2009: Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection American Journal of Obstetrics and Gynecology 200(5): 489.E1-8
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Haddad, L.B.; Cwiak, C.; Jamieson, D.J.; Feldacker, C.; Tweya, H.; Hosseinipour, M.; Hoffman, I.; Bryant, A.G.; Stuart, G.S.; Noah, I.; Mulundila, L.; Samala, B.; Mayne, P.; Phiri, S. 2013: Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate Contraception 88(6): 737-743
Tomasicchio, M.; Avenant, C.; Du Toit, A.; Ray, R.M.; Hapgood, J.P. 2013: The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor PLOS one 8(5): E62895